Literature DB >> 25618269

Metabolomics in critical care medicine: a new approach to biomarker discovery.

Mohammad M Banoei1, Sarah J Donnelly, Beata Mickiewicz, Aalim Weljie, Hans J Vogel, Brent W Winston.   

Abstract

PURPOSE: To present an overview and comparison of the main metabolomics techniques (1H NMR, GC-MS, and LC-MS) and their current and potential use in critical care medicine. SOURCE: This is a focused review, not a systematic review, using the PubMed database as the predominant source of references to compare metabolomics techniques. PRINCIPAL
FINDINGS: 1H NMR, GC-MS, and LC-MS are complementary techniques that can be used on a variety of biofluids for metabolomics analysis of patients in the Intensive Care Unit (ICU). These techniques have been successfully used for diagnosis and prognosis in the ICU and other clinical settings; for example, in patients with septic shock and community-acquired pneumonia.
CONCLUSION: Metabolomics is a powerful tool that has strong potential to impact diagnosis and prognosis and to examine responses to treatment in critical care medicine through diagnostic and prognostic biomarker and biopattern identification.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25618269     DOI: 10.25011/cim.v37i6.22241

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  12 in total

Review 1.  Metabolomics: Applications and Promise in Mycobacterial Disease.

Authors:  Mehdi Mirsaeidi; Mohammad Mehdi Banoei; Brent W Winston; Dean E Schraufnagel
Journal:  Ann Am Thorac Soc       Date:  2015-09

Review 2.  Recent Advances in NMR-Based Metabolomics.

Authors:  G A Nagana Gowda; Daniel Raftery
Journal:  Anal Chem       Date:  2016-12-02       Impact factor: 6.986

3.  New Strategies and Challenges in Lung Proteomics and Metabolomics. An Official American Thoracic Society Workshop Report.

Authors:  Russell P Bowler; Chris H Wendt; Michael B Fessler; Matthew W Foster; Rachel S Kelly; Jessica Lasky-Su; Angela J Rogers; Kathleen A Stringer; Brent W Winston
Journal:  Ann Am Thorac Soc       Date:  2017-12

4.  Shedding metabo'light' on the search for sepsis biomarkers.

Authors:  Claudia C Dos Santos
Journal:  Crit Care       Date:  2015-07-07       Impact factor: 9.097

5.  Specific Metabolome Profile of Exhaled Breath Condensate in Patients with Shock and Respiratory Failure: A Pilot Study.

Authors:  Brice Fermier; Hélène Blasco; Emmanuel Godat; Cinzia Bocca; Joseph Moënne-Loccoz; Patrick Emond; Christian R Andres; Marc Laffon; Martine Ferrandière
Journal:  Metabolites       Date:  2016-09-01

6.  Plasma metabolomics for the diagnosis and prognosis of H1N1 influenza pneumonia.

Authors:  Mohammad M Banoei; Hans J Vogel; Aalim M Weljie; Anand Kumar; Sachin Yende; Derek C Angus; Brent W Winston
Journal:  Crit Care       Date:  2017-04-19       Impact factor: 9.097

7.  Plasma lipid profiling for the prognosis of 90-day mortality, in-hospital mortality, ICU admission, and severity in bacterial community-acquired pneumonia (CAP).

Authors:  Mohammad M Banoei; Hans J Vogel; Aalim M Weljie; Sachin Yende; Derek C Angus; Brent W Winston
Journal:  Crit Care       Date:  2020-07-27       Impact factor: 9.097

Review 8.  Systems Biology ARDS Research with a Focus on Metabolomics.

Authors:  Sayed M Metwaly; Brent W Winston
Journal:  Metabolites       Date:  2020-05-19

Review 9.  Evolution of ARDS biomarkers: Will metabolomics be the answer?

Authors:  Sayed Metwaly; Andreanne Cote; Sarah J Donnelly; Mohammad M Banoei; Ahmed I Mourad; Brent W Winston
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-06-28       Impact factor: 5.464

10.  Development of metabolic and inflammatory mediator biomarker phenotyping for early diagnosis and triage of pediatric sepsis.

Authors:  Beata Mickiewicz; Graham C Thompson; Jaime Blackwood; Craig N Jenne; Brent W Winston; Hans J Vogel; Ari R Joffe
Journal:  Crit Care       Date:  2015-09-09       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.